The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.
Also called NCT04573049
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 124 participants
- Registry
-
NCT04573049
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04573049. Randomized; quadruple masking; primary purpose prevention. Start 2020-09-01 (actual); primary completion 2022-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
- Condition
- Aortic Valve Stenosis
- Condition
- Heart Failure
- Condition
- Inotropic Agents
- Condition
- Safety Issues
- Condition
- Effect of Drug
- Condition
- Cardiac Event
- Intervention (Drug)
- Levosimendan
- Intervention (Other)
- Placebo
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Collaborator
- China International Medical Foundation
Record details
- Record id
cardio:ct-nct04573049- Content hash
80a108fb4736644a9d0f26ba79e16936f573b0b988e96c3f27b1edf17b1e63b7